SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:gup.ub.gu.se/179468"
 

Search: onr:"swepub:oai:gup.ub.gu.se/179468" > CSF biomarker varia...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Mattsson, Niklas,1979Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi,Institute of Neuroscience and Physiology (author)

CSF biomarker variability in the Alzheimer's Association quality control program

  • Article/chapterEnglish2013

Publisher, publication year, extent ...

  • 2013-05
  • Wiley,2013

Numbers

  • LIBRIS-ID:oai:gup.ub.gu.se/179468
  • https://gup.ub.gu.se/publication/179468URI
  • https://doi.org/10.1016/j.jalz.2013.01.010DOI

Supplementary language notes

  • Language:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Background The cerebrospinal fluid (CSF) biomarkers amyloid beta 1–42, total tau, and phosphorylated tau are used increasingly for Alzheimer's disease (AD) research and patient management. However, there are large variations in biomarker measurements among and within laboratories. Methods Data from the first nine rounds of the Alzheimer's Association quality control program was used to define the extent and sources of analytical variability. In each round, three CSF samples prepared at the Clinical Neurochemistry Laboratory (Mölndal, Sweden) were analyzed by single-analyte enzyme-linked immunosorbent assay (ELISA), a multiplexing xMAP assay, or an immunoassay with electrochemoluminescence detection. Results A total of 84 laboratories participated. Coefficients of variation (CVs) between laboratories were around 20% to 30%; within-run CVs, less than 5% to 10%; and longitudinal within-laboratory CVs, 5% to 19%. Interestingly, longitudinal within-laboratory CV differed between biomarkers at individual laboratories, suggesting that a component of it was assay dependent. Variability between kit lots and between laboratories both had a major influence on amyloid beta 1–42 measurements, but for total tau and phosphorylated tau, between-kit lot effects were much less than between-laboratory effects. Despite the measurement variability, the between-laboratory consistency in classification of samples (using prehoc-derived cutoffs for AD) was high (>90% in 15 of 18 samples for ELISA and in 12 of 18 samples for xMAP). Conclusions The overall variability remains too high to allow assignment of universal biomarker cutoff values for a specific intended use. Each laboratory must ensure longitudinal stability in its measurements and use internally qualified cutoff levels. Further standardization of laboratory procedures and improvement of kit performance will likely increase the usefulness of CSF AD biomarkers for researchers and clinicians.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Andreasson, Ulf,1968Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi,Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry(Swepub:gu)xaulfz (author)
  • Persson, Staffan,1974Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi,Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry(Swepub:gu)xpesta (author)
  • Carrillo, M. C. (author)
  • Collins, S. (author)
  • Chalbot, S. (author)
  • Cutler, N. (author)
  • Dufour-Rainfray, D. (author)
  • Fagan, A. M. (author)
  • Heegaard, N. H. H. (author)
  • Hsiung, G. Y. R. (author)
  • Hyman, B. (author)
  • Iqbal, K. (author)
  • Lachno, D. R. (author)
  • Lleo, A. (author)
  • Lewczuk, P. (author)
  • Molinuevo, J. L. (author)
  • Parchi, P. (author)
  • Regeniter, A. (author)
  • Rissman, R. (author)
  • Rosenmann, H. (author)
  • Sancesario, G. (author)
  • Schroder, J. (author)
  • Shaw, L. M. (author)
  • Teunissen, C. E. (author)
  • Trojanowski, J. Q. (author)
  • Vanderstichele, H. (author)
  • Vandijck, M. (author)
  • Verbeek, M. M. (author)
  • Zetterberg, Henrik,1973Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi,Institute of Neuroscience and Physiology(Swepub:gu)xzethe (author)
  • Blennow, Kaj,1958Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi,Institute of Neuroscience and Physiology(Swepub:gu)xbleka (author)
  • Kaser, S. A. (author)
  • Göteborgs universitetInstitutionen för neurovetenskap och fysiologi (creator_code:org_t)

Related titles

  • In:Alzheimers & Dementia: Wiley9:3, s. 251-2611552-52601552-5279

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view